Philogen SpA (MIL:PHIL) EBITDA Margin % : -1,727.73% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Philogen SpA EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Philogen SpA's EBITDA for the six months ended in Jun. 2024 was €-13.46 Mil. Philogen SpA's Revenue for the six months ended in Jun. 2024 was €0.78 Mil. Therefore, Philogen SpA's EBITDA margin for the quarter that ended in Jun. 2024 was -1,727.73%.

Philogen SpA EBITDA Margin % Historical Data

The historical data trend for Philogen SpA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen SpA EBITDA Margin % Chart

Philogen SpA Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

-220.30

-519.83

-4.94

-8.62

Philogen SpA Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBITDA Margin %	Get a 7-Day Free Trial				27.03	-107.66	47.24	-811.23	-1,727.73

Competitive Comparison of Philogen SpA's EBITDA Margin %

For the Biotechnology subindustry, Philogen SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Philogen SpA's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Philogen SpA's EBITDA Margin % falls into.

Philogen SpA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Philogen SpA's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.993	/	23.13
	=	-8.62 %

Philogen SpA's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-13.459	/	0.779
	=	-1,727.73 %

Philogen SpA (MIL:PHIL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Philogen SpA EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Philogen SpA's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen SpA (MIL:PHIL) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

78Q:Germany

Address

Piazza La Lizza No. 7, Siena, ITA, 53100

Website

https://www.philogen.com

Philogen SpA is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. The company's focus is predominantly related to oncology drug development, although the company has also brought products for the treatment of chronic inflammatory diseases to the clinic. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, the company operates in the European Union, Switzerland, and the United States of America.